FRTX logo

FRTX Stock Overview

Profile

Full Name:

Fresh Tracks Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 10, 1993

Indexes:

Not included

Website:

http://ir.frtx.com

Description:

Fresh Tracks Therapeutics (FRTX) is a biopharmaceutical company focused on developing innovative treatments for patients with serious health conditions. They aim to improve patient outcomes through advanced therapies, particularly in areas with high unmet medical needs. Their work combines science and compassion to enhance healthcare solutions.

Key Details

Price

$0.94

Market Cap

$5.59 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$8.01 M(+15.31% YoY)

Annual EPS

-$1.06(+85.89% YoY)

PE Ratio

-

Annual ROE

-66.50%

Annual Debt To Equity

0.00

Beta

0.27

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Mar 5, 2025

Recent annual earnings:

Mar 9, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jul 5, 2022

Analyst ratings

Recent major analysts updates

Aug 16, 22 HC Wainwright & Co.
Buy

Screeners with FRTX included

Stocks cheaper than 1 dollar
US stocks
Most recommended stocks
Best performing stocks last 3 months
Stocks above SMA 50
Healthcare sector
All stocks
NASDAQ Listed Companies
Stocks with high RSI
Earnings this week

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.94
FRTX price is $0.94

Price All-time High

$217350.00
FRTX price is currently -100.00% below its historical high of $217350.00

Price Analysts Target

-
FRTX price consensus analysts' forecast is unknown

Price Most Recent Change

-
FRTX price change on Feb 28, 2025 is unknown

Price YTD Change

+26.35%
FRTX price is up +26.35% since January 1st

Price 3-Year Change

-89.61%
FRTX price is down -89.61% over the past 3 years

Market cap

Market Cap

$5.59 M
FRTX market capitalization is $5.59 million

Market Cap 3-Year Change

-76.61%
FRTX market capitalization is down -76.61% over the past 3 years

Market Cap All-time High

$1.11 B
FRTX market capitalization is currently -99.50% below its historical high of $1.11 billion

Market Cap Sector Rank

13.25%
FRTX market capitalization is higher than 13.25% of companies in Healthcare sector

Technical

Beta

0.27
FRTX beta is 0.27

200-day SMA

$0.82
FRTX price is currently +14.02% above its 200-day simple moving average

14-day RSI

73.75
FRTX 14-day relative strength index is 73.75

30-day Relative Volume

0.90
FRTX 30-day relative volume is 0.90

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$8.01 M
FRTX annual revenue is $8.01 million

Annual Revenue Analysts Estimate

$6.00 M
FRTX annual revenue is currently +33.43% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

+15.31%
FRTX annual revenue is up +15.31% year-on-year

Annual Revenue Sector Rank

30.26%
FRTX annual revenue is higher than 30.26% of companies in Healthcare sector

Profit

Annual Gross Profit

-
FRTX annual gross profit value is unknown

Annual Gross Margin

-
FRTX annual gross profit margin value is unknown

Annual Operating Profit

-$6.36 M
FRTX annual operating income is -$6.36 million

Annual Operating Margin

-79.44%
FRTX annual operating profit margin is -79.44%

Annual Net Income

-$5.69 M
FRTX annual net profit is -$5.69 million

Annual Net Margin

-71.12%
FRTX annual net profit margin is -71.12%

EPS

Annual EPS

-$1.06
FRTX annual earnings per share is -$1.06

Annual EPS Analysts Estimate

-
FRTX annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+85.89%
FRTX annual earnings per share is up +85.89% year-on-year

Annual EPS Sector Rank

57.64%
FRTX annual earnings per share is higher than 57.64% of companies in Healthcare sector

ROA & ROE

Annual ROA

-52.10%
FRTX annual return on assets is -52.10%

Annual ROE

-66.50%
FRTX annual return on equity is -66.50%

EBIT & EBITDA

Annual EBIT

-$5.69 M
FRTX annual earnings before interest & taxes is -$5.69 million

Annual EBITDA

-$5.65 M
FRTX annual EBITDA is -$5.65 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
FRTX price to earnings ratio value is unknown

PE Ratio Sector Rank

-
FRTX price to earnings ratio is unknown

PB Ratio

PB Ratio

0.56
FRTX price to book ratio is 0.56

PB Ratio Sector Rank

30.07%
FRTX price to book ratio is higher than 30.07% of companies in Healthcare sector

PS Ratio

PS Ratio

-
FRTX price to sales ratio value is unknown

PS Ratio Sector Rank

-
FRTX price to sales ratio is unknown

Enterprise value

Enterprise Value

-$5.28 M
FRTX enterprise value is -$5.28 million

Enterprise Value Sector Rank

6.14%
FRTX enterprise value is higher than 6.14% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.94
FRTX EV/EBITDA is 0.94

EV/EBITDA Sector Rank

75.13%
FRTX EV/EBITDA is higher than 75.13% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

6.98
FRTX annual current ratio is 6.98

Annual Quick Ratio

-
FRTX annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
FRTX annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-1137.80
FRTX annual interest coverage ratio is -1137.80

Risk & Stability

Piotroski F-Score

-
FRTX piotroski f-score value is unknown

Altman Z-Score

-18.68
FRTX altman z-score is -18.68

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$11.59 M
FRTX annual total assets is $11.59 million

Annual Non Current Assets

$34.00 K
FRTX annual long term assets is $34.00 thousand

Annual Current Assets

$11.55 M
FRTX annual total current assets is $11.55 million

Annual Cash & Cash Equivalents

$10.87 M
FRTX annual cash & cash equivalents is $10.87 million

Equity

Annual Book Value

$9.93 M
FRTX annual book value is $9.93 million

Annual Working Capital

$9.90 M
FRTX annual working capital is $9.90 million

Liabilities

Annual Total Liabilities

$1.66 M
FRTX annual total liabilities is $1.66 million

Annual Total Long Term Liabilities

$0.00
FRTX annual total long term liabilities is $0.00

Annual Current Liabilities

$1.66 M
FRTX annual total current liabilities is $1.66 million

Annual Accounts Payable

$406.00 K
FRTX annual accounts payable is $406.00 thousand

Debt

Annual Total Debt

$0.00
FRTX annual total debt is $0.00

Annual Total Debt 1-Year Change

-100%
FRTX annual total debt is down -100% year-on-year

Annual Long Term Debt

-
FRTX annual long term debt value is unknown

Annual Short Term Debt

$0.00
FRTX annual short term debt is $0.00

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$14.37 M
FRTX annual total expenses is $14.37 million

Annual Operating Expenses

$14.37 M
FRTX annual total operating expenses is $14.37 million

Annual Cost Of Goods Sold

-
FRTX annual cost of goods sold value is unknown

Annual SGA

$11.18 M
FRTX annual SGA is $11.18 million

Annual D&A

$41.00 K
FRTX annual depreciation & amortization is $41.00 thousand

Annual Interest Expense

$5000.00
FRTX annual interest expense is $5000.00

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$4.34 M
FRTX annual cash flow from operations is -$4.34 million

Annual CFO 1-Year Change

+77.54%
FRTX annual cash flow from operations is up +77.54% year-on-year

Annual CFI

$0.00
FRTX annual cash flow from investing activities is $0.00

Annual CFI 1-Year Change

+100%
FRTX annual cash flow from investing activities is up +100% year-on-year

Annual CFF

$6.53 M
FRTX annual cash flow from financing activities is $6.53 million

Annual CFF 1-Year Change

+454.41%
FRTX annual cash flow from financing activities is up +454.41% year-on-year

Free CashFlow

Annual FCF

-$4.34 M
FRTX annual free cash flow is -$4.34 million

Annual FCF 1-Year Change

+77.59%
FRTX annual free cash flow is up +77.59% year-on-year

CAPEX

Annual CAPEX

-
FRTX annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
FRTX annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

CJJD logo
China Jo-Jo Drugstores (CJJD)
Ridgetech (RDGT)
NUWE logo
Nuwellis (NUWE)
EVOK logo
Evoke Pharma (EVOK)
LIFW logo
MSP Recovery (LIFW)
XBIO logo
Xenetic Biosciences (XBIO)
GLTO logo
Galecto (GLTO)
SNGX logo
Soligenix (SNGX)
XWEL logo
XWELL (XWEL)

FAQ

  • What is the ticker symbol for Fresh Tracks Therapeutics?
  • Does Fresh Tracks Therapeutics pay dividends?
  • What sector is Fresh Tracks Therapeutics in?
  • What industry is Fresh Tracks Therapeutics in?
  • What country is Fresh Tracks Therapeutics based in?
  • When did Fresh Tracks Therapeutics go public?
  • Is Fresh Tracks Therapeutics in the S&P 500?
  • Is Fresh Tracks Therapeutics in the NASDAQ 100?
  • Is Fresh Tracks Therapeutics in the Dow Jones?
  • When was Fresh Tracks Therapeutics's last earnings report?
  • When does Fresh Tracks Therapeutics report earnings?
  • Should I buy Fresh Tracks Therapeutics stock now?

What is the ticker symbol for Fresh Tracks Therapeutics?

The ticker symbol for Fresh Tracks Therapeutics is NASDAQ:FRTX

Does Fresh Tracks Therapeutics pay dividends?

No, Fresh Tracks Therapeutics does not pay dividends

What sector is Fresh Tracks Therapeutics in?

Fresh Tracks Therapeutics is in the Healthcare sector

What industry is Fresh Tracks Therapeutics in?

Fresh Tracks Therapeutics is in the Biotechnology industry

What country is Fresh Tracks Therapeutics based in?

Fresh Tracks Therapeutics is headquartered in United States

When did Fresh Tracks Therapeutics go public?

Fresh Tracks Therapeutics's initial public offering (IPO) was on March 10, 1993

Is Fresh Tracks Therapeutics in the S&P 500?

No, Fresh Tracks Therapeutics is not included in the S&P 500 index

Is Fresh Tracks Therapeutics in the NASDAQ 100?

No, Fresh Tracks Therapeutics is not included in the NASDAQ 100 index

Is Fresh Tracks Therapeutics in the Dow Jones?

No, Fresh Tracks Therapeutics is not included in the Dow Jones index

When was Fresh Tracks Therapeutics's last earnings report?

Fresh Tracks Therapeutics's most recent earnings report was on Mar 5, 2025

When does Fresh Tracks Therapeutics report earnings?

The date for Fresh Tracks Therapeutics's next earnings report has not been announced yet

Should I buy Fresh Tracks Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions